BioSyent, Inc. (RX.V)
13.96
-0.04
(-0.29%)
CAD |
TSXV |
May 29, 16:00
BioSyent Total Liabilities (Quarterly) : 17.50M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 101.20M |
| Bausch Health Cos., Inc. | 35.70B |
| Cipher Pharmaceuticals, Inc. | 28.65M |
| Revive Therapeutics Ltd. | 4.001M |
| Knight Therapeutics, Inc. | 299.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 62.49M |
| Shareholders Equity (Quarterly) | 44.99M |
| Debt to Equity Ratio | 0.1166 |
| Current Ratio | 1.891 |
| Net Debt Paydown Yield | -0.51% |